News

Vitaquest Opens New Particle Engineering Facility

Company Expands Manufacturing Capabilities & Industry Leadership with 4th Facility, Introduces Fluidized Bed Process TechnologiesWest Caldwell, New Jersey--(Newsfile Corp. -…

2 years ago

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -…

2 years ago

Masimo and Denon Introduce White PerL™ and PerL Pro™ Earbuds, Redefining Style and Customization in Personalized Audio

The only earbuds on the market that analyze your hearing profile to generate truly custom sound made just for youIRVINE,…

2 years ago

Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected…

2 years ago

NervGen Pharma Reports Q1 2024 Financial Results and Operational Updates

Target for completing enrollment of the chronic cohort in the Phase 1b/2a clinical trial moved to Q3 2024Subacute cohort protocol…

2 years ago

Bio Conscious Announces Strategic API Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings

Endobits Automated Remote Patient Management Platform Will Now Deploy Its Industry-Leading AI-Powered Software to Securely Integrate Dexcom CGM Data VANCOUVER,…

2 years ago

NIKKI Wins Approval at Cellcore Exclusive ECO24 Event

VANCOUVER, BC / ACCESSWIRE / May 16, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited…

2 years ago

FSD Pharma Provides Update on Celly Nu’s New Packaging for unbuzzd(TM)

TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way…

2 years ago

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing…

2 years ago

Formula Swiss Sues Office for Consumer Protection in Kanton Zug Over CBD Product Classification

CHAMERSTRASSE, SWITZERLAND / ACCESSWIRE / May 16, 2024 / In the ever-evolving world of cannabis and CBD, where products are…

2 years ago